To view this email as a web page, click here.

Comparing Laparoscopic vs Open Surgery for Colorectal Liver Metastases

Data from the randomized OSLO-COMET trial were presented at ASCO 2019, revealing the survival of laparoscopic vs open surgery for liver metastases in colorectal cancer.

Dr. Mehmet Sitki Copur on the Most Exciting Research Presented at ASCO 2019

Cancer Network spoke with Mehmet Sitki Copur, MD, FACP, medical oncologist at the Morrison Cancer Center, about the most exciting research presented at ASCO in 2019.

IN CASE YOU MISSED IT

Practice-Changing Results Seen in Phase III Relapsed/Refractory AML Trial

Results of the phase III ADMIRAL trial, which tested the FLT3 inhibitor gilteritinib in patients with relapsed/refractory acute myeloid leukemia, were presented at the AACR Annual Meeting.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.